🇺🇸 FDA
Patent

US 9005617

Antikine antibodies that bind to multiple CC chemokines

granted A61PA61P29/00A61P37/02

Quick answer

US patent 9005617 (Antikine antibodies that bind to multiple CC chemokines) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P29/00, A61P37/02, A61P37/06, A61P43/00